Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7357523rdf:typepubmed:Citationlld:pubmed
pubmed-article:7357523lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7357523lifeskim:mentionsumls-concept:C0000768lld:lifeskim
pubmed-article:7357523lifeskim:mentionsumls-concept:C0085957lld:lifeskim
pubmed-article:7357523lifeskim:mentionsumls-concept:C2709248lld:lifeskim
pubmed-article:7357523lifeskim:mentionsumls-concept:C0001963lld:lifeskim
pubmed-article:7357523lifeskim:mentionsumls-concept:C0185115lld:lifeskim
pubmed-article:7357523lifeskim:mentionsumls-concept:C1364081lld:lifeskim
pubmed-article:7357523lifeskim:mentionsumls-concept:C1706554lld:lifeskim
pubmed-article:7357523lifeskim:mentionsumls-concept:C1709915lld:lifeskim
pubmed-article:7357523lifeskim:mentionsumls-concept:C0065973lld:lifeskim
pubmed-article:7357523pubmed:issue6lld:pubmed
pubmed-article:7357523pubmed:dateCreated1980-5-23lld:pubmed
pubmed-article:7357523pubmed:abstractTextEight of 64 patients receiving intravenous administration of methanol extraction residue (MER) of Bacillus Calmette-Guerin (BCG), developed miliary-type pulmonary parenchymal changes. The clinical and radiological characteristics are described. An increased incidence was noted in patients with a history of previous BCG exposure or with positive PPD skin reactivity. Spontaneous resolution was observed upon discontinuation of MER. These changes most likely respresent a granulomatous inflammatory process, although no histological confirmation was obtained.lld:pubmed
pubmed-article:7357523pubmed:languageenglld:pubmed
pubmed-article:7357523pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7357523pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7357523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7357523pubmed:statusMEDLINElld:pubmed
pubmed-article:7357523pubmed:monthMarlld:pubmed
pubmed-article:7357523pubmed:issn0008-543Xlld:pubmed
pubmed-article:7357523pubmed:authorpubmed-author:HershE MEMlld:pubmed
pubmed-article:7357523pubmed:authorpubmed-author:GuttermanJ...lld:pubmed
pubmed-article:7357523pubmed:authorpubmed-author:LibshitzH IHIlld:pubmed
pubmed-article:7357523pubmed:authorpubmed-author:QuesadaJ RJRlld:pubmed
pubmed-article:7357523pubmed:issnTypePrintlld:pubmed
pubmed-article:7357523pubmed:day15lld:pubmed
pubmed-article:7357523pubmed:volume45lld:pubmed
pubmed-article:7357523pubmed:ownerNLMlld:pubmed
pubmed-article:7357523pubmed:authorsCompleteYlld:pubmed
pubmed-article:7357523pubmed:pagination1340-3lld:pubmed
pubmed-article:7357523pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:meshHeadingpubmed-meshheading:7357523-...lld:pubmed
pubmed-article:7357523pubmed:year1980lld:pubmed
pubmed-article:7357523pubmed:articleTitlePulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of Bacillus Calmette-Guerin.lld:pubmed
pubmed-article:7357523pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7357523pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7357523pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed